Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.300
-0.020 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
3.530
+0.230 (6.97%)
After-hours: Apr 28, 2026, 6:32 PM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$781,109
Market Cap
2.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 29 |
| BiomX | 20 |
| Silexion Therapeutics | 14 |
| Adial Pharmaceuticals | 5 |
| CNS Pharmaceuticals | 5 |
| Oragenics | 3 |
BDRX News
- 26 days ago - Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies - GlobeNewsWire
- 4 weeks ago - Preliminary Results for the Year Ended 31 December 2025 - GlobeNewsWire
- 5 weeks ago - Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group - GlobeNewsWire
- 5 weeks ago - ADR Ratio Change - GlobeNewsWire
- 7 weeks ago - Biodexa Announces Support for Life's a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients - GlobeNewsWire
- 2 months ago - Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer - Accesswire
- 2 months ago - Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST - GlobeNewsWire
- 4 months ago - Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary - GlobeNewsWire